Healthcare -
Biotechnology - NASDAQ - US
$ 14.69
3.89 %
$ 1.49 B
Market Cap
-4.1
P/E
DYN - OPERATING EXPENSES
Operating Expenses DYN - Dyne Therapeutics, Inc.
242 M
LAST VALUE
27.05%
2 YEAR CAGR
119.11%
5 YEAR CAGR
9.58%
10 YEAR CAGR